elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26796415-02EFD4C2-9076-4E26-A107-029A57FB9800
Q26796415-02EFD4C2-9076-4E26-A107-029A57FB9800
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26796415-02EFD4C2-9076-4E26-A107-029A57FB9800
Pharmacologic therapy for inflammatory bowel disease refractory to steroids
P2860
Q26796415-02EFD4C2-9076-4E26-A107-029A57FB9800
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26796415-02EFD4C2-9076-4E26-A107-029A57FB9800
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
28e8c4ebf9275b2c6e2236879a0e6b134e23aa75
P2860
Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed.